Susquehanna Fundamental Investments LLC grew its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 1,031.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,584 shares of the company's stock after purchasing an additional 152,770 shares during the period. Susquehanna Fundamental Investments LLC owned approximately 0.14% of Definitive Healthcare worth $915,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of DH. Norden Group LLC acquired a new position in shares of Definitive Healthcare during the 1st quarter valued at $83,000. Conestoga Capital Advisors LLC lifted its stake in shares of Definitive Healthcare by 1.3% during the first quarter. Conestoga Capital Advisors LLC now owns 5,595,627 shares of the company's stock worth $45,157,000 after purchasing an additional 74,490 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in shares of Definitive Healthcare in the first quarter valued at about $290,000. Oppenheimer Asset Management Inc. grew its stake in shares of Definitive Healthcare by 40.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 49,393 shares of the company's stock valued at $399,000 after buying an additional 14,229 shares in the last quarter. Finally, Swiss National Bank raised its holdings in shares of Definitive Healthcare by 2.9% during the 1st quarter. Swiss National Bank now owns 103,300 shares of the company's stock valued at $834,000 after buying an additional 2,900 shares during the period. Hedge funds and other institutional investors own 98.67% of the company's stock.
Definitive Healthcare Stock Up 0.2 %
NASDAQ:DH traded up $0.01 during mid-day trading on Thursday, reaching $4.35. The stock had a trading volume of 345,401 shares, compared to its average volume of 803,778. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The company has a market capitalization of $513.02 million, a price-to-earnings ratio of -2.48, a price-to-earnings-growth ratio of 6.49 and a beta of 1.33. Definitive Healthcare Corp. has a 1-year low of $3.19 and a 1-year high of $10.62. The stock's 50 day simple moving average is $4.39 and its two-hundred day simple moving average is $5.64.
Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The company had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. During the same quarter last year, the firm earned $0.08 EPS. The business's revenue was up 4.4% on a year-over-year basis. Equities analysts anticipate that Definitive Healthcare Corp. will post 0.07 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on DH. BTIG Research assumed coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price target for the company. Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a "buy" rating for the company in a research note on Wednesday, July 31st. Robert W. Baird dropped their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 7th. Needham & Company LLC restated a "hold" rating on shares of Definitive Healthcare in a research note on Tuesday, August 6th. Finally, Barclays dropped their target price on Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $5.81.
Check Out Our Latest Stock Analysis on Definitive Healthcare
About Definitive Healthcare
(
Free Report)
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
See Also
Before you consider Definitive Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.
While Definitive Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
